Journal profile · Oncology
Cancer Prevention Research
ISSN 1940-6207 · eISSN 1940-6215 · American Association for Cancer Research Inc. · UNITED STATES · Monthly · Founded 2008
Cancer Prevention Research: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.32; hybrid open access; median 147 days to acceptance (96 articles, last 24 months); 87 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cancer Prevention Research is published by American Association for Cancer Research Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer, Lipids, and Metabolism, Cancer Risks and Factors and Inflammatory mediators and NSAID effects, together about 22.1% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Cancer Prevention Research publishes original studies, reviews, and perspectives in the field of cancer prevention. Its scope includes the molecular and cellular biology of premalignancy and early lesions; genetic and environmental risk factors; risk assessment and reduction; early detection research (cancer screening and diagnosis); and preventive interventions (chemoprevention, immunoprevention, and others) to intercept cancer development at early stages prior to initiation, promotion, or progression. The journal comprises preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis on building a translational bridge between the basic and clinical sciences.
Source: LetPub
Research area (LetPub): Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer, Lipids, and MetabolismBiochemistry, Genetics and Molecular Biology8.4%
- Cancer Risks and FactorsMedicine7.6%
- Inflammatory mediators and NSAID effectsMedicine6.1%
- Nutrition, Genetics, and DiseaseBiochemistry, Genetics and Molecular Biology5.8%
- Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology5.4%
- Genetic factors in colorectal cancerMedicine5%
- Colorectal Cancer Screening and DetectionMedicine5%
- Global Cancer Incidence and ScreeningMedicine4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.32LetPub ·
- CiteScore 2026-06
- 4.9LetPub ·
- SJR 2026-06
- 1.13LetPub ·
- SNIP 2026-06
- 0.77LetPub ·
- h-index
- 80LetPub ·
- h-index
- 132OpenAlex ·
- i10-index
- 1,646OpenAlex ·
- 2-year mean citedness
- 2.97OpenAlex ·
- Self-citation rate
- 2.9%LetPub ·
- Share of gold OA articles
- 24.43%LetPub ·
Volume
- Articles per year
- 60LetPub ·
Articles by year OpenAlex count · 4,348 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 53 | 19 | 13 |
| 2025 | 87 | 55 | 184 |
| 2024 | 77 | 45 | 447 |
| 2023 | 166 | 52 | 559 |
| 2022 | 202 | 97 | 986 |
| 2021 | 97 | 83 | 1,533 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
147 daysMedian, submission to acceptance · P25–P75 89 days – 206 days
- Acceptance to online
- median 4 days (16 articles)
- Submission to online
- median 157 days
- Sample
- 96 articles with submission and acceptance dates (148 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- American Association for Cancer Research Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 2008
- ISSN
- 1940-6207
- Electronic ISSN
- 1940-6215
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Cancer Prevention Research
What CAS zone is Cancer Prevention Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cancer Prevention Research is in Zone 3 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cancer Prevention Research?
The latest impact factor listed by LetPub is 3.32; CiteScore 4.9, h-index 132.
How long does peer review take at Cancer Prevention Research?
Based on the dates recorded on 96 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 147 days (interquartile range 89–206 days); authors report an average review time of 4–8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Cancer Prevention Research?
According to LetPub and DOAJ records, Cancer Prevention Research is indexed in SCIE and Scopus.
Is Cancer Prevention Research open access, and what is the APC?
Cancer Prevention Research is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .